histidine has been researched along with Parkinson Disease in 30 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (13.33) | 18.7374 |
1990's | 1 (3.33) | 18.2507 |
2000's | 9 (30.00) | 29.6817 |
2010's | 15 (50.00) | 24.3611 |
2020's | 1 (3.33) | 2.80 |
Authors | Studies |
---|---|
Chiu, YW; Hirayama, K; Hori, Y; Ikeda, T; Iwai, A; Iwata, A; Kanai, M; Mano, T; Nakamura, R; Sohma, Y; Suzuki, T; Tarutani, A; Toda, T; Tomita, T; Tomizawa, I | 1 |
Conedera, S; Daida, K; Funayama, M; Hattori, N; Ikeda, A; Li, Y; Matsushima, T; Nakajima, S; Nishioka, K; Oyama, G; Yoshino, H | 1 |
Chatterji, T; Gupta, M; Nagesh Babu, G; Paliwal, VK; Roy, R; Singh, S | 1 |
Aasly, JO; Appel-Cresswell, S; Encarnacion, M; Farrer, MJ; Jon Stoessl, A; Rajput, A; Rajput, AH; Shah, B; Sherman, H; Szu-Tu, C; Thompson, C; Trinh, J; Vilarino-Guell, C; Weir, D; Yu, I | 1 |
Chen, CM; Chen, WL; Lee, CM; Lee-Chen, GJ; Lin, CH; Wang, HC; Wu, YR | 1 |
Armstrong, GS; Chi, YC; Eisenmesser, EZ; Jones, DN; Liu, CW | 1 |
Cai, Z; Chen, LL; Chua, KK; Li, M; Liu, LF; Luan, H; Meng, N; Mok, VC; Song, JX; Tang, Z; Xie, LX | 1 |
Becker, CM; Hoffmann, AC; Klucken, J; Meixner, H; Menges, S; Schlachetzki, JC; Schlötzer-Schrehardt, U; Winkler, J; Xiang, W | 1 |
Kumar, A; Ranjan, P | 1 |
Aasly, JO; Cobb, SA; Dachsel, JC; Farrer, MJ; Felic, A; Haugarvoll, K; Johansen, KK; Kachergus, JM; Lincoln, SJ; Nutt, JG; Payami, H; Ross, OA; Soto-Ortolaza, AI; Toft, M; Vilariño-Güell, C; Webber, PJ; West, AB; White, LR; Wider, C | 1 |
Batabyal, D; Johnson, KA; McKenzie, JL | 1 |
Baratto, MC; Camponeschi, F; Kozlowski, H; Luczkowski, M; Remelli, M; Valensin, D; Valensin, G | 1 |
Acosta, O; Alvarez, V; Avello, R; Bacon, JA; Cornejo-Olivas, M; Cosentino, C; Díaz-Grez, F; Dieguez, E; Farrer, MJ; Layson, L; Marca, V; Mata, IF; Mazzetti, P; Medina, AC; Micheli, F; Miranda, M; Ortega, O; Perandones, C; Perez-Pastene, C; Raggio, V; Ross, OA; Segura-Aguilar, J; Torres, L; Trujillo-Godoy, O; Venegas, P; Vilariño-Güell, C; Wilhoite, GJ; Yearout, D; Zabetian, CP | 1 |
Cobb, SA; Englund, E; Farrer, MJ; Kachergus, JM; Lincoln, SJ; Nilsson, C; Puschmann, A; Rehncrona, S; Ross, OA; Törnqvist, AL; Vilariño-Güell, C; Widner, H; Wszolek, ZK | 1 |
Bao, AM; Hofman, MA; Shan, L; Swaab Dick, F; Van Someren, EJ; van Wamelen, DJ | 1 |
Burgunder, J; Cao, B; Chen, K; Chen, X; Chen, Y; Guo, X; Huang, R; Li, J; Shang, HF; Song, W; Zhao, B | 1 |
Giasson, BI; Hodara, R; Ischiropoulos, H; Lee, VM; Norris, EH; Trojanowski, JQ; Xu, S | 1 |
Cookson, MR | 1 |
Gaggelli, E; Kozlowski, H; Valensin, D; Valensin, G | 1 |
Latsoudis, H; Plaitakis, A; Spanaki, C | 1 |
Farrer, MJ; Gibson, JM; Gosal, D; Haugarvoll, K; Lynch, T; Ross, OA | 1 |
Agid, Y; Bonnet, AM; Borg, M; Brice, A; Broussolle, E; Damier, P; Destée, A; Durif, F; Dürr, A; Janin, S; Layet, V; Leclere, L; Lesage, S; Leutenegger, AL; Lohmann, E; Martinez, M; Penet, C; Pollak, P; Rasco, O; Thobois, S; Tison, F; Tranchan, C; Vérin, M; Viallet, F; Vidailhet, M | 1 |
Chen, Z; Hu, DN; Liu, CQ; Liu, FX; Luo, JH | 1 |
Arosio, P; Biasiotto, G; Finazzi, D; Goldwurm, S; Pezzoli, G; Sironi, F; Tunesi, S; Zecchinelli, A | 1 |
Nakajima, T | 1 |
Ahmadi, A; Akerbäck, A; Axelson, O; Fall, PA; Fredrikson, M; Jerregârd, H; Rannug, A; Söderkvist, P | 1 |
Daniel, PM; Moorhouse, RS; Pratt, OE | 1 |
berger, H; jarosch, E; Ludescher, E | 1 |
Lavinha, F; Lowenthal, A; Mardens, Y; Van Regemorter, N; Van Sande, M | 1 |
Sakharova, AV; Stepanova, VG | 1 |
2 review(s) available for histidine and Parkinson Disease
Article | Year |
---|---|
Copper homeostasis and neurodegenerative disorders (Alzheimer's, prion, and Parkinson's diseases and amyotrophic lateral sclerosis).
Topics: Adenosine Triphosphatases; Alzheimer Disease; Amyloid beta-Peptides; Amyotrophic Lateral Sclerosis; Animals; Copper; Histidine; Homeostasis; Humans; Mice; Models, Chemical; Models, Molecular; Molecular Conformation; Molecular Structure; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Prion Diseases; Protein Binding | 2006 |
Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Depressive Disorder; Droxidopa; Histidine; Humans; Levodopa; Parkinson Disease | 1996 |
28 other study(ies) available for histidine and Parkinson Disease
Article | Year |
---|---|
Photo-oxygenation of histidine residue inhibits α-synuclein aggregation.
Topics: alpha-Synuclein; Histidine; Humans; Lewy Bodies; Parkinson Disease; Respiratory Physiological Phenomena | 2023 |
A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease.
Topics: Arginine; DNA-Binding Proteins; Histidine; Humans; Mitochondrial Proteins; Mutation; Parkinson Disease; Transcription Factors | 2017 |
Serum metabolomics study in a group of Parkinson's disease patients from northern India.
Topics: Aged; Alanine; Female; Glutamine; Histidine; Humans; India; Isoleucine; Male; Metabolomics; Middle Aged; Multiple System Atrophy; Parkinson Disease; Proton Magnetic Resonance Spectroscopy; Supranuclear Palsy, Progressive; Valine | 2018 |
Alpha-synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease.
Topics: alpha-Synuclein; Glutamine; Histidine; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Pedigree | 2013 |
Variant R244H in Na+/Mg2+ exchanger SLC41A1 in Taiwanese Parkinson's disease is associated with loss of Mg2+ efflux function.
Topics: Adult; Arginine; Asian People; Case-Control Studies; Cation Transport Proteins; Cohort Studies; DNA Mutational Analysis; Female; Genetic Variation; HEK293 Cells; Histidine; Humans; Magnesium; Male; Parkinson Disease; Taiwan; Transfection | 2014 |
Residue histidine 50 plays a key role in protecting α-synuclein from aggregation at physiological pH.
Topics: alpha-Synuclein; Amino Acid Substitution; Buffers; Electrochemistry; Histidine; Humans; Hydrogen-Ion Concentration; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Unfolded Protein Response | 2014 |
LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.
Topics: alpha-Synuclein; Animals; Biomarkers; Chromatography, Liquid; Drosophila melanogaster; Fatty Acids; Histidine; Humans; Kynurenine; Mass Spectrometry; Metabolomics; Nucleotides; Parkinson Disease; Phenotype; Phenylalanine; Steroids; Tryptophan; Tyrosine | 2015 |
Posttranslational modification and mutation of histidine 50 trigger alpha synuclein aggregation and toxicity.
Topics: alpha-Synuclein; Cell Death; Cells, Cultured; Histidine; Humans; Mutation; Neurons; Parkinson Disease; Protein Aggregates; Protein Processing, Post-Translational | 2015 |
The Involvement of His50 during Protein Disulfide Isomerase Binding Is Essential for Inhibiting α-Syn Fibril Formation.
Topics: alpha-Synuclein; Amino Acid Substitution; Amyloid; Animals; Histidine; Humans; Mutation, Missense; Parkinson Disease; Protein Disulfide-Isomerases | 2016 |
Novel pathogenic LRRK2 p.Asn1437His substitution in familial Parkinson's disease.
Topics: Aged; Aged, 80 and over; Asparagine; Cell Line, Transformed; Female; Genetic Testing; Guanosine Triphosphate; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Norway; Parkinson Disease; Protein Serine-Threonine Kinases; Psychiatric Status Rating Scales; Tomography, Emission-Computed, Single-Photon; Transfection | 2010 |
Role of histidine 932 of the human mitochondrial DNA polymerase in nucleotide discrimination and inherited disease.
Topics: Base Pair Mismatch; Catalysis; Cloning, Molecular; Diphosphates; DNA; DNA-Directed DNA Polymerase; Genome, Mitochondrial; Histidine; Humans; Kinetics; Mitochondria; Mutagenesis; Mutation; Nucleotides; Parkinson Disease | 2010 |
The role of His-50 of α-synuclein in binding Cu(II): pH dependence, speciation, thermodynamics and structure.
Topics: alpha-Synuclein; Amino Acid Sequence; Binding Sites; Circular Dichroism; Copper; Electron Spin Resonance Spectroscopy; Histidine; Humans; Hydrogen-Ion Concentration; Models, Molecular; Molecular Sequence Data; Nuclear Magnetic Resonance, Biomolecular; Parkinson Disease; Thermodynamics | 2011 |
Lrrk2 p.Q1111H substitution and Parkinson's disease in Latin America.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amino Acid Substitution; Case-Control Studies; Female; Glutamine; Histidine; Humans; Indians, South American; Latin America; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Protein Serine-Threonine Kinases; Young Adult | 2011 |
First neuropathological description of a patient with Parkinson's disease and LRRK2 p.N1437H mutation.
Topics: Aged; alpha-Synuclein; Asparagine; Brain; DNA Mutational Analysis; DNA-Binding Proteins; Family Health; Female; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Magnetic Resonance Imaging; Male; Parkinson Disease; Protein Serine-Threonine Kinases; RNA-Binding Protein FUS; Ubiquitin | 2012 |
Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases.
Topics: Alzheimer Disease; Case-Control Studies; Circadian Rhythm; Gene Expression; Histamine; Histidine; Humans; Huntington Disease; Hydantoins; Hypothalamic Area, Lateral; In Situ Hybridization; Neurodegenerative Diseases; Parkinson Disease | 2012 |
VPS35 Asp620Asn and EIF4G1 Arg1205His mutations are rare in Parkinson disease from southwest China.
Topics: Adult; Aged; Arginine; Asparagine; Aspartic Acid; Case-Control Studies; China; Eukaryotic Initiation Factor-4G; Female; Histidine; Humans; Male; Middle Aged; Mutation; Parkinson Disease; Vesicular Transport Proteins; Young Adult | 2013 |
Reversible inhibition of alpha-synuclein fibrillization by dopaminochrome-mediated conformational alterations.
Topics: alpha-Synuclein; Amino Acid Motifs; Circular Dichroism; DNA, Complementary; Dopamine; Histidine; Humans; Indolequinones; Methionine; Microscopy, Atomic Force; Microscopy, Electron; Mutagenesis; Mutation; Nerve Tissue Proteins; Oxidative Stress; Oxygen; Parkinson Disease; Peptides; Protein Conformation; Protein Structure, Secondary; Recombinant Proteins; Spectroscopy, Fourier Transform Infrared; Synucleins; Time Factors; Tyrosine | 2005 |
Neurons inflict self-harm.
Topics: Cysteine; Dopamine; Histidine; Models, Biological; Mutation; Neurons; Neuroprotective Agents; Parkinson Disease; Protein Folding; Protein Structure, Tertiary; Solubility; Substantia Nigra; Ubiquitin-Protein Ligases | 2005 |
LRRK2 mutations on Crete: R1441H associated with PD evolving to PSP.
Topics: Age of Onset; Aged; Aged, 80 and over; Arginine; Cohort Studies; Dementia; Disease Progression; Female; Genetic Predisposition to Disease; Greece; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Pedigree; Protein Serine-Threonine Kinases; Supranuclear Palsy, Progressive | 2006 |
Global distribution and reduced penetrance: Lrrk2 R1441C in an Irish Parkinson's disease kindred.
Topics: Arginine; Binding Sites; Disease Progression; Glycine; Histidine; Humans; Ireland; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Parkinson Disease; Penetrance; Point Mutation; Protein Serine-Threonine Kinases | 2007 |
LRRK2 exon 41 mutations in sporadic Parkinson disease in Europeans.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; DNA Mutational Analysis; Europe; Exons; Female; Histidine; Humans; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Male; Middle Aged; Mutation; Parkinson Disease; Protein Serine-Threonine Kinases; Serine; Threonine; Tyrosine | 2007 |
Involvement of brain endogenous histamine in the degeneration of dopaminergic neurons in 6-hydroxydopamine-lesioned rats.
Topics: Analysis of Variance; Animals; Behavior, Animal; Brain; Cell Count; Disease Models, Animal; Dopamine; Enzyme Inhibitors; Histamine; Histamine Agents; Histidine; Male; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
HFE gene mutations in a population of Italian Parkinson's disease patients.
Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Cysteine; DNA Mutational Analysis; Female; Gene Frequency; Genotype; Hemochromatosis Protein; Histidine; Histocompatibility Antigens Class I; Humans; Italy; Male; Membrane Proteins; Middle Aged; Mutation; Parkinson Disease; Serine | 2008 |
GSTM1 and mEPHX polymorphisms in Parkinson's disease and age of onset.
Topics: Adult; Age of Onset; Aged; Alleles; Epoxide Hydrolases; Gene Frequency; Genetic Carrier Screening; Glutathione Transferase; Histidine; Homozygote; Humans; Isoenzymes; Male; Middle Aged; Odds Ratio; Parkinson Disease; Polymorphism, Genetic; Reference Values | 2000 |
Letter: Do changes in blood levels of other aromatic aminoacids influence levodopa therapy?
Topics: Amino Acids; Blood-Brain Barrier; Histidine; Humans; Levodopa; Parkinson Disease; Phenylalanine; Tryptophan | 1976 |
[Disturbance of the Histidine Reabsorption of the Renal Tubes in Patient with Cystine Lysinuria in Conjunction with Severe Cerebral Damage (author's transl)].
Topics: Amino Acid Metabolism, Inborn Errors; Brain Damage, Chronic; Child; Cystinuria; Histidine; Humans; Intellectual Disability; Kidney Tubules; Levodopa; Lysine; Male; Parkinson Disease | 1975 |
[Distribution of two peptides of -aminobutyric acid in human brain and CSF].
Topics: Adolescent; Adult; Aged; Aging; Aminobutyrates; Brain Chemistry; Cerebral Cortex; Child; Child, Preschool; Chromatography, Ion Exchange; Dipeptides; Histidine; Humans; Infant; Lysine; Middle Aged; Parkinson Disease; Phenylketonurias | 1972 |
[The protein nature of specific cellular inclusions (Lewy's bodies) in Parkinson's disease].
Topics: Acetylcholinesterase; Acid Phosphatase; Alkaline Phosphatase; Amino Acids; Cholinesterases; Cystine; Cytoplasmic Granules; Histidine; Histocytochemistry; Humans; Lipase; Lysine; Microscopy, Electron; Neurons; Parkinson Disease; Proteins; Substantia Nigra; Sulfites; Tryptophan; Tyrosine | 1967 |